A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Methocarbamol Tablets (Methocarbamol)

Muscle Relaxant class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2018-05-15
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$0.037/unit
5 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.041
Across all dosage forms in distribution.
Highest NADAC
$0.044
Range is tight.
Plans with PA
112 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Methocarbamol Tablets used for?

Methocarbamol Tablets is a Muscle Relaxant medication tracked in Medicare Part D.

Is there a generic for Methocarbamol Tablets?

No. Methocarbamol Tablets is brand-only with no generic equivalents currently in market.

How much does my plan pay for Methocarbamol Tablets?

Across 329 Part D plans, Methocarbamol Tablets averages $0.041/unit (NADAC). Lowest available: $0.037/unit. Highest in distribution: $0.044/unit.

Is Methocarbamol Tablets on the FDA shortage list?

No. Methocarbamol Tablets is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Muscle Relaxant5 alternatives in D1
01
Carisoprodol
Brand: Soma
$0.067Lowest NADAC
13Generic mfrs
$8.4MCY24 Part D spend
Compare →
02
Chlorzoxazone
Muscle Relaxant
$0.215Lowest NADAC
11Generic mfrs
$24.2MCY24 Part D spend
Compare →
03
Metaxalone
Muscle Relaxant
$0.377Lowest NADAC
6Generic mfrs
$12.6MCY24 Part D spend
Compare →
04
Methocarbamol
Brand: ATMEKSI
$0.037Lowest NADAC
18Generic mfrs
$65.6MCY24 Part D spend
Compare →
05
Orphenadrine
Muscle Relaxant
$0.458Lowest NADAC
7Generic mfrs
$3.5MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (5 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.